Objective: Proton pencil beam scanning (PBS) treatment fields needs to be verified before treatment deliveries to ensure patient safety. In current practice, treatment beam quality assurance (QA) is measured at a few selected depths using film or a 2D detector array, which is insensitive and time-consuming. A QA device that can measure all key dosimetric characteristics of treatment beams spot-by-spot within a single beam delivery is highly desired. Approach: We developed a multi-layer strip ionization chamber (MLSIC) prototype device that comprises of two layers of strip ionization chambers (IC) plates for spot position measurement and 64 layers of plate ionization chambers for beam energy measurement. The 768-channel strip ion chamber signal are integrated and sampled at a speed of 3.125 kHz. It has a 25.6 cm × 25.6 cm maximum measurement field size and 2 mm spatial resolution for spot position measurement. The depth resolution and maximum depth were 2.91 mm and 18.6 cm for 1.6 mm thick IC plate, respectively. The relative weight of each spot was determined from total charge by all IC detector channels. Main results: The MLSIC is able to measure ionization currents spot-by-spot. The depth dose measurement has a good agreement with the ground truth measured using a water tank and commercial 1D multi-layer plate chamber. It can verify the spot position, energy, and relative weight of clinical PBS beams and compared with the treatment plans. Significance: MLSIC is a highly efficient QA device that can measure the key dosimetric characteristics of proton treatment beams spot-by-spot with a single beam delivery. It may improve the quality and efficiency of clinical proton treatments.
Distributed x-ray sources enable novel designs of x-ray imaging systems. However, the x-ray power of such sources is limited by the focal spot power density of the fixed anode. To further improve x-ray output, we have designed and evaluated a diamond-W transmission target for multi-pixel x-ray sources. The target features a thin layer of tungsten deposited on a diamond substrate. The thickness of tungsten layer was optimized for maximum fluence through Monte Carlo simulations. Finite element thermal simulations were performed to evaluate focal spot temperature in the target under different power loadings and dwell duration. The results showed that the optimal thickness of the tungsten layer in the W-diamond transmission target is linearly proportional to the electron energy. A 5-6 μm tungsten thickness is suitable for the kVps ranges from 60 kVp to 140 kVp. A W-diamond transmission target produces up to 20% more x-ray fluence than a traditional W reflection target in the beam center depending on the kVp settings. The x-ray spectrum of the transmission target shows less characteristic x-rays than that of reflection target. The thermal performance of W-diamond targets for peak power is significantly better than that of reflection targets. The maximum focal spot power densities of W-diamond transmission and W reflection targets are both strongly dependent on the dwell duration. For longer pulse durations, the W-diamond target allows as much as a four-fold increase in power and an eight-fold increase in power density in comparison to a traditional W reflection target for the same temperature spikes. The stability of the W-diamond bond needs to be tested experimentally. Nevertheless, the W-diamond transmission target is an appealing target that can significantly simplify the design and improve the performance of distributed x-ray sources.
Purpose: The objective of this study was to investigate the dosimetric impact of range uncertainty in a large cohort of patients receiving passive scatter proton therapy.Methods: A cohort of 120 patients were reviewed in this study retrospectively, of which 61 were brain, 39 lung, and 20 prostate patients. Range uncertainties of ±3.5% (overshooting and undershooting by 3.5%, respectively) were added and recalculated on the original plans, which had been planned according to our clinical planning protocol while keeping beamlines, apertures, compensators, and dose grids intact. Changes in the coverage on CTV and DVH for critical organs were compared and analyzed. Correlation between dose change and minimal distance between CTV and critical organs were also investigated.Results: Although CTV coverages and maximum dose to critical organs were largely maintained for most brain patients, large variations over 5% were still observed sporadically. Critical organs, such as brainstem and chiasm, could still be affected by range uncertainty at 4 cm away from CTV. Coverage and OARs in lung and prostate patients were less likely to be affected by range uncertainty with very few exceptions. Conclusion:The margin recipe in modern TPS leads to clinically acceptable OAR doses in the presence of range uncertainties. However, range uncertainties still pose a noticeable challenge for small but critical serial organs near tumors, and occasionally for large parallel organs that are located distal to incident proton beams.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.